Publication | Closed Access

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

Dose-finding StudyHematological MalignancyHematologyLong-term Extension StudyPharmacotherapyLower-risk Myelodysplastic SyndromesMedicineAplastic AnemiaAnesthesiology